These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 28745689)

  • 1. [Kidney injury molecules (KIM-1, MCP-1) and type IV collagen in the assessment of activity of antineutrophil cytoplasmic antibody-associated glomerulonephritis].
    Bulanov NM; Serova AG; Kuznetsova EI; Bulanova ML; Novikov PI; Kozlovskaya LV; Moiseev SV
    Ter Arkh; 2017; 89(6):48-55. PubMed ID: 28745689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.
    Lieberthal JG; Cuthbertson D; Carette S; Hoffman GS; Khalidi NA; Koening CL; Langford CA; Maksimowicz-McKinnon K; Seo P; Specks U; Ytterberg SR; Merkel PA; Monach PA;
    J Rheumatol; 2013 May; 40(5):674-83. PubMed ID: 23547217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?
    de Souza AW; Abdulahad WH; Sosicka P; Bijzet J; Limburg PC; Stegeman CA; Bijl M; Westra J; Kallenberg CG
    Clin Exp Immunol; 2014 Nov; 178(2):270-8. PubMed ID: 25052363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Moran SM; Monach PA; Zgaga L; Cuthbertson D; Carette S; Khalidi NA; Koening CL; Langford CA; McAlear CA; Moreland L; Pagnoux C; Seo P; Specks U; Sreih A; Wyse J; Ytterberg SR; Merkel PA; Little MA;
    Nephrol Dial Transplant; 2020 Feb; 35(2):283-291. PubMed ID: 30380100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of cathelicidin LL37 in human anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitis.
    Zhang Y; Shi W; Tang S; Li J; Yin S; Gao X; Wang L; Zou L; Zhao J; Huang Y; Shan L; Gounni AS; Wu Y; Yuan F; Zhang J
    Arthritis Res Ther; 2013 Oct; 15(5):R161. PubMed ID: 24286516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN.
    Gou SJ; Yuan J; Wang C; Zhao MH; Chen M
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1884-91. PubMed ID: 24115193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis.
    Shah S; Havill J; Rahman MH; Geetha D
    Clin Rheumatol; 2016 Apr; 35(4):953-60. PubMed ID: 26445939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary angiotensinogen: an indicator of active antineutrophil cytoplasmic antibody-associated glomerulonephritis.
    Wu L; Yang M; Feng X; Jin L; Wu C; Cui S; Zhou Z; Zhong X; Shi M; Yang Z; Cao W
    Nephrol Dial Transplant; 2019 May; 34(5):838-847. PubMed ID: 29733413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement Components C3 and C4 Indicate Vasculitis Manifestations to Distinct Renal Compartments in ANCA-Associated Glomerulonephritis.
    Hakroush S; Tampe D; Korsten P; Ströbel P; Tampe B
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological analysis of ANCA-associated glomerulonephritis focusing on plasma cell infiltrate.
    Masuzawa N; Nishimura A; Mihara Y; Tamagaki K; Konishi E
    Clin Exp Nephrol; 2019 Dec; 23(12):1373-1381. PubMed ID: 31485791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and outcome of double-seropositive patients with anti-glomerular basement membrane antibodies and anti-neutrophil cytoplasmic antibodies.
    Ge Y; Zhu J; Yang G; Liu K; Yu X; Sun B; Zhang B; Yuan Y; Zeng M; Wang N; Xing C; Mao H
    Int Immunopharmacol; 2024 Sep; 138():112607. PubMed ID: 38981222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum decoy receptor 3 levels are associated with the disease activity of MPO-ANCA-associated renal vasculitis.
    Maruyama H; Hirayama K; Nagai M; Ebihara I; Shimohata H; Kobayashi M
    Clin Rheumatol; 2016 Oct; 35(10):2469-76. PubMed ID: 27251675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of ANCA serology in ANCA-associated vasculitis with renal involvement.
    Cohen A; Weerasinghe N; Lemmert K; de Malmanche T; Myint T
    Intern Med J; 2024 Sep; 54(9):1497-1505. PubMed ID: 38873696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters?
    Sharma A; Nada R; Naidu GS; Minz RW; Kohli HS; Sakhuja V; Gupta KL; Rathi M
    Int J Rheum Dis; 2016 Jan; 19(1):74-81. PubMed ID: 26269223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Aminoacyl-tRNA Synthetase-Interacting Multifunctional Protein-1 Can Predict Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Pilot Monocentric Study.
    Ahn SS; Kim JO; Yoon T; Song JJ; Park YB; Lee SW; Park SG
    Biomed Res Int; 2019; 2019():7508240. PubMed ID: 31236412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
    Geetha D; Sethi S; De Vriese AS; Specks U; Kallenberg CGM; Lim N; Spiera R; St Clair EW; Merkel PA; Seo P; Monach PA; Lepori N; Fessler BJ; Langford CA; Hoffman GS; Sharma R; Stone JH; Fervenza FC;
    Am J Nephrol; 2017; 46(3):231-238. PubMed ID: 28881339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of the determination of urinary excretion of kidney injury molecule-1 (KIM-1) in the assessment of the activity and prognosis of chronic glomerulonephritis].
    Brovko MY; Pulin AA; Kustova TY; Sholomova VI; Loshkareva OA; Taranova MV; Kozlovskaya LV
    Ter Arkh; 2016; 88(6):51-57. PubMed ID: 27296262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.
    Tam FW; Sanders JS; George A; Hammad T; Miller C; Dougan T; Cook HT; Kallenberg CG; Gaskin G; Levy JB; Pusey CD
    Nephrol Dial Transplant; 2004 Nov; 19(11):2761-8. PubMed ID: 15353578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis.
    Rhee RL; Davis JC; Ding L; Fervenza FC; Hoffman GS; Kallenberg CGM; Langford CA; McCune WJ; Monach PA; Seo P; Spiera R; St Clair EW; Specks U; Stone JH; Merkel PA
    Clin J Am Soc Nephrol; 2018 Feb; 13(2):251-257. PubMed ID: 29371340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.